actriib receptor ectodomain (R&D Systems)
93
Structured Review
R&D Systems
actriib receptor ectodomain
Actriib Receptor Ectodomain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/Recombinant+Human+Activin+RIIA+Fc+Chimera+Protein/pm36563024-99-25-31
Average 93 stars, based on 14 article reviews
Actriib Receptor Ectodomain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/Recombinant+Human+Activin+RIIA+Fc+Chimera+Protein/pm36563024-99-25-31
Average 93 stars, based on 14 article reviews
actriib receptor ectodomain - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Recombinant:Article Title: Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor Article Snippet: .. Four different recombinant BMP9 receptors can be used: Article Title: Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7 Article Snippet: .. Recombinant human ActRIIA-Fc and Article Title: Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7 Article Snippet: Recombinant human ActE was provided by R&D Systems through Alnylam Pharmaceuticals and validated using a luciferase reporter assay ( ). .. Recombinant human ActRIIA-Fc and Article Title: Pathogenic ACVR1 R206H activation by Activin A-induced receptor clustering and autophosphorylation. Article Snippet: For Activin A blocking experiments, follistatin 288 (Sigma) was reconstituted in PBS and used at a final concentration of 500 ng/ml. .. Control:Article Title: Anti-activin A antibodies and uses thereof Article Snippet: The ability of selected anti-Activin A antibodies to block the interaction of Activin A with its receptors, ActRIIB and ActRIIA, as well as its endogenous antagonist, Follistatin, was determined using a Biacore 3000 instrument. .. For this experiment, Control 4 (human ActRIIB expressed with a C-terminal human Fc tag (SEQ ID:227)), human ActRIIA expressed with a C-terminal Binding Assay:Article Title: Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation. Article Snippet: 1Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany 2Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany 3Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden 4Colzyx AB, Lund, Sweden 5Medical Faculty, Institute for Dental Research and Oral Musculoskeletal Biology, University of Cologne, Cologne, Germany 6Institute of Biochemistry, University of Cologne, Cologne, Germany 7Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany 8Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany 9Cologne Center for Musculoskeletal Biomechanics (CCMB), Cologne, Germany |